• Nenhum resultado encontrado

Extract of Adenanthera pavonina L. seed reduces development of diabetic nephropathy in streptozotocin-induced diabetic rats

N/A
N/A
Protected

Academic year: 2017

Share "Extract of Adenanthera pavonina L. seed reduces development of diabetic nephropathy in streptozotocin-induced diabetic rats"

Copied!
10
0
0

Texto

Loading

Imagem

Table 2. Effect of Adenanthera pavonina seed aqueous extract on serum lipid profile of normal and diabetic rats
Table 3. Effects of Adenanthera pavonina seed aqueous extract on serum parameters of normal and diabetic rats
Table 4. Effect of Adenanthera pavonina seed aqueous extract on Urine parameters of normal and diabetic rats

Referências

Documentos relacionados

I read with interest the article entitled ‘‘Antihyperlipi- demic effect of Peucedanum pastinacifolium extract in streptozotocin-induced diabetic rats’’ by Ahmad Mova- hedian et al..

It was also observed that diabetic rats showed altered levels of blood urea, serum creatinine, and albumin, and the albumin/globulin ratio was signi fi cantly reversed by treatment

OBJECTIVE Considering the importance of the im- mune system in the development of diabetic complications such as higher susceptibility to infections in diabetic patients, we

A recent study has shown that Sirt1 deiciency is associated with the pathogenesis of both podocyte injury and proximal tubular cell damage in diabetic nephropathy, and

In an experimental study to investigate the role of PPAR α in type 1 diabetic nephropathy, more severe structural changes (such as glomerulosclerosis and mesangial area

Although diabetic nephropathy is classified into five stages in “Classification of Diabetic Nephropathy 2014” [1], it does not always proceed from one stage to the next orderly;

In conclusion, within its limitations, this study showed that the serum levels of adiponectin were increased in insulin-treated diabetic rats in the pres- ence

The RENAAL study 4 comparing iosartan x placebo in diabetic patients with nephropathy, showed a significant risk reduction in the primary outcomes of serum creatine